G0143 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision

Name of the Procedure:

Screening Cytopathology (Cervical or Vaginal)
Common Names: Pap Test, Pap Smear
Technical/Medical Terms: Cervical Cytology, Vaginal Cytology, G0143

Summary

A Pap test is a screening method used to detect precancerous or cancerous cells in the cervix or vagina. The cells are collected using a special brush and placed in a preservative fluid, followed by automated thin layer preparation, and manually screened by a cytotechnologist under a physician's supervision.

Purpose

The Pap test aims to detect human papillomavirus (HPV)-related changes, precancerous conditions, or cervical cancer early. Detecting abnormalities prompt early intervention, which is vital for successful treatment and preventing progression to more severe disease.

Indications

• Routine screening for cervical cancer in women ages 21-65
• Monitoring for women with a history of cervical dysplasia or HPV
• Symptoms like unusual vaginal bleeding or discharge
• Part of a gynecological examination

Preparation

• Generally, no fasting required.
• Avoid vaginal intercourse, douching, or using vaginal medications for 24-48 hours before the test.

• Schedule the test when not menstruating, if possible.

  Procedure Description

  1. The patient lies on an examination table with feet placed in stirrups.
  2. A speculum is gently inserted to widen the vaginal canal.
  3. A special brush or spatula collects cells from the cervix.
  4. Collected cells are placed in a preservative fluid.
  5. Cells are processed using automated thin layer preparation technology.
  6. A cytotechnologist examines the cells under a microscope manually, followed by a physician's review.

  Tools/Equipment: Speculum, cytology brush/spatula, preservative fluid, microscope, automated thin layer preparation machine.

Anesthesia/Sedation: None typically required.

Duration

The actual cell collection takes about 5-10 minutes. Preparing and analyzing the samples can take a few days.

Setting

Typically performed in an outpatient clinic, gynecologist's office, or healthcare center.

Personnel

• Gynecologist or trained healthcare provider (e.g., nurse practitioner)
• Cytotechnologist
• Physician for supervisory review

Risks and Complications

• Mild discomfort or cramping during the procedure
• Spotting or light bleeding afterward
• Rare risk of infection or injury to the cervix

Benefits

• Early detection of precancerous changes or cervical cancer
• High potential for successful treatment if abnormalities are found early
• Peace of mind when results are normal

Recovery

• Resume normal activities immediately.
• Some light spotting or cramping may be experienced.
• Follow-up as recommended based on results (normally every 3 to 5 years for routine screening).

Alternatives

• HPV DNA test: More specific for detecting the presence of high-risk HPV types.
• Visual inspection with acetic acid (VIA): Used in low-resource settings.
• Primary HPV screening: More widely adopted in recent years.

Pros of Pap test:

• Well-established and widely available.

  Cons of Pap test:

• Might miss some high-grade lesions if not combined with HPV testing.

Patient Experience

• During the procedure, patients may feel slight discomfort when the speculum is inserted.
• Post-procedure, minor cramping or light bleeding may occur.
• Most patients can manage mild discomfort with over-the-counter pain relievers if needed.